Teva Pharmaceutical Industries (TEVA) Dividend Coverage Ratio Growth (1y) (2010 - 2018)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Dividend Coverage Ratio Growth (1y) (2010 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.98 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -2,482.61% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 522.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.65 Mn | 365.40 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 5,144.68% |
| Dec 31, 2017 | -4,344.44% |
| Sep 30, 2017 | 320.99% |
| Jun 30, 2017 | -2,984.44% |
| Mar 31, 2017 | -9.72% |
| Dec 31, 2016 | -279.38% |
| Sep 30, 2016 | 185.20% |
| Jun 30, 2016 | -67.60% |
| Mar 31, 2016 | 20.73% |
| Dec 31, 2015 | 45.33% |
| Sep 30, 2015 | -87.84% |
| Jun 30, 2015 | -24.89% |
| Mar 31, 2015 | -40.17% |
| Dec 31, 2014 | 145.44% |
| Sep 30, 2014 | 9.32% |
| Jun 30, 2014 | 247.41% |
| Mar 31, 2014 | 11.81% |
| Dec 31, 2013 | -33.16% |
| Sep 30, 2013 | 942.21% |
| Jun 30, 2013 | -144.63% |